Enhertu Approved as HER2-Directed Therapy for Certain Lung Cancer Patients

The FDA granted a new indication for trastuzumab deruxtecan-nxki (Enhertu, AstraZeneca/Daiichi Sankyo) to treat ...

AUGUST 15, 2022